Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome

Fig. 6

OS of MDS patients stratified by the expressions of HOXB-AS3 in different IPSS risk groups. a OS in the patients with IPSS low or intermediate-1 risk, stratified by HOXB-AS3 expressions. b OS in the patients with IPSS intermediate-2 or high risk, stratified by HOXB-AS3 expressions. The patients were stratified by the expressions of transcript cluster: TC17002858.hg.1 on Affymetrix GeneChip® HTA 2.0 arrays into 2 groups as Fig. 5b

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us